Neoadjuvant Chemotherapy for Resectable Non–Small-Cell Lung Cancer
ByJhanelle E. Gray, MD,Eric Sommers, MD,Miguel Alvelo-rivera, MD,Lary Robinson, MD,Gerold Bepler, MD, PhD
Published: | Updated:
Lung cancer is the most common cancer diagnosed in men and women in the United States, and is the leading cause of cancer death.Over 160,000 individuals died as a result of lung cancer in 2008.[1] This number amounted to more than the number of deaths from colon, breast, and prostate cancers combined. The majority of lung cancer cases are non–small-cell lung cancer (NSCLC), and the poor outcomes are attributed to the high rate of metastases associated with this disease.